InsidersTradesSigma
H. Lundbeck A/S Stock: price and directors' dealings · Denmark · Finanstilsynet DK
Follow the H. Lundbeck A/S stock price and the full management transaction log of the company, a listed equity based in Denmark. Shares are quoted on DK DK, under the authority of Finanstilsynet DK. Operating in the Health Care sector, H. Lundbeck A/S has recorded 63 insider filings. Market capitalisation: €39.8bn. The latest transaction was filed on 16 February 2024 (Purchase). Among the most active insiders: Unknown. All data is free.
63
Insider Decl.
0
Thresholds
€923,063
30 ops.
Buy Volume
€18m
17 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate H. Lundbeck A/S Buy (bullish), based on 12 analysts. Average price target: DKK 47.21.
13Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 1,659 of 26,211 companies
77.4
score / 100
Value79
Quality76
FCF yld12%
Earn yld7.7%
EV/EBITDA7.8x
ROE15%
Gross mgn83%
Net mgn13%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 16 February 2024
Declarations63 total
22,529 shares@ DKK 33.320.0003% mcap0.3% of flowShareDK:1275549
Ideal exit: 11 Nov 2024 (T+270)
6,737 shares0ShareDK:1273307
1,679 shares@ DKK 149.590.0001% mcap0.1% of flowShareDK:1139553
Ideal exit: 8 Nov 2022 (T+270)
3,385 shares@ DKK 147.460.0002% mcap0.2% of flowShareDK:1139190
Ideal exit: 7 Nov 2022 (T+270)
2,439 shares@ DKK 200.100.0002% mcap0.2% of flowShareDK:1033638
Ideal exit: 19 Feb 2022 (T+270)
ShareIssued by Lundbeck LLCDK:924852
ShareDK:920591
1,225 shares@ DKK 246.200.0001% mcap0.1% of flowShareDK:910897
Ideal exit: 7 Aug 2020 (T+270)
29,500 shares@ DKK 268.000.0027% mcap3.1% of flowShareDK:891142
4,000 shares@ DKK 266.700.0004% mcap0.4% of flowShareDK:890977
3,500 shares@ DKK 272.620.0003% mcap0.4% of flowShareDK:889374
Ideal exit: 3 Feb 2020 (T+270)
80,000 shares@ DKK 352.790.0095% mcap11.1% of flowShareNASDAQ Copenhagen XCSEDK:811725
100,000 shares@ DKK 156.160.0053% mcap6.2% of flowShareOutside a trading venue (the shares will be listed onDK:811147
ShareNASDAQ Copenhagen XCSEDK:789043
150,000 shares@ DKK 387.660.020% mcap22.9% of flowShareDK:788844
160,000 shares@ DKK 156.160.0084% mcap9.9% of flowShareDK:787682
22,927 shares@ DKK 380.300.0029% mcap3.4% of flowShareDK:786811
23,500 shares@ DKK 370.050.0029% mcap3.4% of flowShareDK:786533
400,000 shares@ DKK 156.160.021% mcap24.6% of flowShareOutside a trading venue (the shares will be listed onDK:775541
19,796 shares@ DKK 341.630.0023% mcap2.7% of flowShareNASDAQ Copenhagen XCSEDK:774449
15,000 shares@ DKK 242.010.0012% mcap1.4% of flowShareNASDAQ Copenhagen XCSEDK:744665
Ideal exit: 4 Aug 2017 (T+270)
12,500 shares@ DKK 245.300.0010% mcap1.2% of flowShareNASDAQ Copenhagen XCSEDK:744306
39,939 shares@ DKK 262.040.0035% mcap4.1% of flowShareNASDAQ Copenhagen XCSEDK:726955
42,478 shares@ DKK 126.660.0018% mcap2.1% of flowShareNASDAQ Copenhagen XCSEDK:724724
42,478 shares@ DKK 126.660.0018% mcap2.1% of flowShareH. Lundbeck A/S (the subscribed for shares will be registered onDK:724717
25 of 63 declarations
About H. Lundbeck A/S
H. Lundbeck A/S is a Danish pharmaceutical company focused on developing treatments for psychiatric and neurological disorders. It emphasizes innovation in medications for conditions such as depression and schizophrenia.